Product ID: 1373154
Reminder: Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastu
Authenticity guarantee
Direct Mail
Privacy packaging
Pharmacy Direct
Description
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy. This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.
Ujvira 100mg Injection is indicated for its use in the following conditions:
Therapeutic Effects of Ujvira 100mg Injection
Trastuzumab binds selectively to the HER2 receptors on breast cancer cells' surface, blocks them from receiving growth signals, and stops the cancer cell's growth. DM1 becomes active once the drug enters the cancer cells and helps stop cancer cell growth.
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Ujvira 100mg Injection and cause undesirable side effects.
Discuss with your physician before taking this Ujvira 100mg Injection if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause to the unborn baby.
Avoid breastfeeding your baby while on the treatment with Ujvira 100mg Injection atleast for at least seven months after the final dose.
Talk to your doctor if you have any lung conditions before starting treatment with Ujvira 100mg Injection.
You need to tell your physician if you have any liver disorders before starting Ujvira 100mg Injection as it requires dosage adjustment for severe liver impairment.
Consult your doctor to know if it is safe to consume alcohol while you are on treatment with Ujvira 100mg Injection.
Ujvira 100mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
Common
